A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study

Trial Profile

A Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of Cannabidiol (CBD; GWP42003-P) in Infants With Infantile Spasms Following an Initial Open-label Pilot Study

Recruiting
Phase of Trial: Phase III

Latest Information Update: 25 Mar 2017

At a glance

  • Drugs Cannabidiol
  • Indications Infantile spasms
  • Focus Adverse reactions
  • Sponsors GW Pharmaceuticals
  • Most Recent Events

    • 17 Mar 2017 Status changed from active, no longer recruiting to recruiting.
    • 17 Mar 2017 Planned End Date changed from 1 Nov 2019 to 1 Jan 2020.
    • 17 Mar 2017 Planned primary completion date changed from 1 Oct 2019 to 1 Dec 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top